These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 115183)
21. [Ultrastructural changes in plague microbes of vaccinal strain EB and alveolar macrophages of guinea pigs during their interaction in vitro]. Pospelova TB; Ternovoĭ VI; Lozovoĭ NV; Golotina NB; Gerasiuk LG Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):58-62. PubMed ID: 7395404 [TBL] [Abstract][Full Text] [Related]
22. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954 [TBL] [Abstract][Full Text] [Related]
23. [Jet immunization with polyvalent vaccine against plague, tularemia, and anthrax]. Loktev NA; Pilipenko VG; Basilova GI; Shchedrin VI; Lunina EA Zh Mikrobiol Epidemiol Immunobiol; 1980 Jun; (6):109-10. PubMed ID: 7445856 [No Abstract] [Full Text] [Related]
24. [Morphofunctional evaluation of the state of cells of APUD-system biomodel during anti-plague vaccine process]. Bugorkova SA; Kutyreva VV Zh Mikrobiol Epidemiol Immunobiol; 2013; (4):49-55. PubMed ID: 24341215 [TBL] [Abstract][Full Text] [Related]
25. [Prophylactic use of ceftriaxone in combination with F I antigen immunization in studies on uninbred albino mice infected by Yersinia pestis. Antiplague immunity development]. Ryzhko IV; Moldavan IA; Tsuraeva RI; Shcherbaniuk AI Antibiot Khimioter; 2006; 51(9-10):8-12. PubMed ID: 18030785 [TBL] [Abstract][Full Text] [Related]
27. Immunity in plague: protection induced in Cercopithecus aethiops by oral administration of live, attenuated Yersinia pestis. Chen TH; Elbert SS; Eisler DM J Infect Dis; 1976 Mar; 133(3):302-9. PubMed ID: 815445 [TBL] [Abstract][Full Text] [Related]
28. [Aerosol-immunization with live vaccines and anatoxins. IV. Characteristics and dynamics of vaccinal processes after aerosol-vaccination with brucellosis, tularemia, anthrax and plague dust-vaccines]. ALEKSANDROV NI; GEFEN NE; GAPOCHKO KG; GARIN NS Zh Mikrobiol Epidemiol Immunobiol; 1960 Dec; 31():38-44. PubMed ID: 13682237 [No Abstract] [Full Text] [Related]
29. [Use of the RSP-1M device in practice for the aerosol immunization of humans with dry plague vaccine]. Fediaev SF; Beliakov VA Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):82-5. PubMed ID: 1221727 [TBL] [Abstract][Full Text] [Related]
30. [Effect of aerosolization on the biological properties of live plague vaccine]. Evstigneev VI; Chicherin IuV; Lebedinskiĭ VA Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):108-11. PubMed ID: 855516 [TBL] [Abstract][Full Text] [Related]
31. Kinetics of memory B cell and plasma cell responses in the mice immunized with plague vaccines. Zhang X; Wang Q; Bi Y; Kou Z; Zhou J; Cui Y; Yan Y; Zhou L; Tan Y; Yang H; Du Z; Han Y; Song Y; Zhang P; Zhou D; Yang R; Wang X Scand J Immunol; 2014 Mar; 79(3):157-62. PubMed ID: 24383627 [TBL] [Abstract][Full Text] [Related]
32. Vaccination against bubonic and pneumonic plague. Titball RW; Williamson ED Vaccine; 2001 Jul; 19(30):4175-84. PubMed ID: 11457543 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of live or killed plague vaccines in man. Meyer KF Bull World Health Organ; 1970; 42(5):653-66. PubMed ID: 4988692 [TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of the serosol method of immunization against plague in acute experiments on guinea pigs]. Zaplatina SI; Gefen NE; Khokhlova AM; Kremlev GI; Krasnova IN; Kaverina-Firgant KG; Fediaev SF Zh Mikrobiol Epidemiol Immunobiol; 1968 Jun; 45(6):84-8. PubMed ID: 5713239 [No Abstract] [Full Text] [Related]
36. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy. Fellows P; Price J; Martin S; Metcalfe K; Krile R; Barnewall R; Hart MK; Lockman H Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691 [TBL] [Abstract][Full Text] [Related]
37. Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis. Meyer KF; Hightower JA; McCrumb FR J Infect Dis; 1974 May; 129():Suppl:S41-5. PubMed ID: 4825248 [No Abstract] [Full Text] [Related]
38. Dual route vaccination for plague with emergency use applications. Moore BD; New RRC; Butcher W; Mahood R; Steward J; Bayliss M; MacLeod C; Bogus M; Williamson ED Vaccine; 2018 Aug; 36(34):5210-5217. PubMed ID: 30017148 [TBL] [Abstract][Full Text] [Related]
39. Prevention of bubonic and pneumonic plague using plant-derived vaccines. Alvarez ML; Cardineau GA Biotechnol Adv; 2010; 28(1):184-96. PubMed ID: 19931370 [TBL] [Abstract][Full Text] [Related]
40. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]